BSEKabra Drugs LtdMinimalNeutral
Announced Fri, 30 May · 19:57 IST

Non-Applicability of Annual Secretarial Report

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kabra Drugs Ltd has informed BSE that the Annual Secretarial Compliance Report for the financial year ended March 31, 2025 is not applicable to the company. The company is claiming exemption under Regulation 15(2) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. It qualifies for this exemption because its paid-up equity share capital is Rs. 23,70,78,500 (approximately Rs. 23.7 Crores) and its net worth does not exceed Rs. 3.28 Crores as on the last day of the previous financial year. Since both thresholds are met, the Corporate Governance provisions — including the requirement to file this report — do not apply to the company.

Likely market impact

This is a routine compliance filing with no material impact on shareholders or the stock price. The company is simply availing an exemption available to smaller listed entities, indicating it remains a small-cap company by net worth.